Home PACS News PACS Corporate News Lung Cancer Screening With Low-Dose CT in the United States
Lung Cancer Screening With Low-Dose CT in the United States PDF Print E-mail
Written by PACSMule Administrator   
Wednesday, 25 November 2015 11:00
The findings of the landmark National Lung Screening Trial (NLST)—showing a 20% reduction in lung cancer mortality when screening with low-dose CT (LDCT), compared with chest radiography—marked a turning point in the field of lung cancer screening, influencing organizational recommendations and leading to increasing acceptance of LDCT for screening of individuals at high risk for lung cancer. However, many practices and institutions have experienced barriers in their attempts to implement successful screening programs; these include challenges in maintaining the same high caliber of screening programs as those in the NLST, confusion regarding insurance reimbursement protocols, and a lack of resources to help physicians discuss the specifics of LDCT screening with their patients.

Read more